The reported transaction involved 17,449 shares valued at ~$3.4 million at the transaction price of $196.31 per share. The disposition represented 14% of the insider's direct equity holdings, includin
Popular (BPOP) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Here's Why Popular (BPOP) is a Strong Value Stock

10:41am, Wednesday, 29'th Jul 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
BPOP's Q2 results benefit from higher NII, fee income and loan and deposit growth. Lower expenses and a planned 20% dividend hike add to the positives.
Popular, Inc. (BPOP) Q2 2026 Earnings Call Transcript

Popular Q2 Earnings Call Highlights

01:07pm, Thursday, 23'rd Jul 2026
Popular NASDAQ: BPOP reported a stronger second quarter, with management citing higher net interest income, solid fee generation, balance sheet growth and stable underlying credit trends, while also a
Popular (BPOP) came out with quarterly earnings of $4.35 per share, beating the Zacks Consensus Estimate of $3.69 per share. This compares to earnings of $3.09 per share a year ago.

Popular Announces Leadership Transition

08:00am, Thursday, 23'rd Jul 2026
SAN JUAN, Puerto Rico--(BUSINESS WIRE)--Popular, Inc. (“Popular” or the “Company”) (NASDAQ: BPOP) announced today that Javier D. Ferrer, the Company's President and Chief Executive Officer, wi
SAN JUAN, Puerto Rico--(BUSINESS WIRE)--Popular, Inc. (the “Corporation,” “Popular,” “we,” “us,” “our”) (NASDAQ: BPOP) FINANCIAL HIGHLIGHTS   ($ in millions, except per share info

Popular Announces Capital Actions

08:00am, Thursday, 23'rd Jul 2026
SAN JUAN, Puerto Rico--(BUSINESS WIRE)--Popular, Inc. (the “Corporation”) (NASDAQ: BPOP) announced today the following capital actions: an increase in the Corporation's quarterly common stock divi
Novo Nordisk (NYSE:NVO) stock is down 1% at $49.14, after the drugmaker filed a lawsuit against rival Eli Lilly (LLY), citing misleading advertising for its GLP-1 drugs.
As space becomes scarce, the company is experimenting with new store formats.
Popular (BPOP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Fractyl Health Inc. (NASDAQ:GUTS) reported Wednesday one-year results from the Midpoint Cohort of its REMAIN-1 study, saying a single treatment with its investigational Revita DMR System helped patien
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE